Midgard Science

Gubra

Hørsholm, Denmark gubra.dk From their website, Nov 2026

Work here? Claim this listing

About

Gubra is a biotech company in Hørsholm, Denmark, with additional sites in Boston, United States, and Basel, Switzerland. It provides preclinical CRO services, drug discovery and development focused on peptide therapeutics, and venture creation and incubation. Its CRO work serves pharmaceutical and biotech companies worldwide.

Services

  • Preclinical contract research services

    Preclinical studies to help pharmaceutical and biotech companies advance drug development pipelines.

  • Liver (MASH) studies

    Validated MASH mouse models and related translational endpoints for efficacy and proof-of-concept work.

  • Obesity studies

    Diet-induced obesity rodent models and efficacy studies with metabolic and body composition endpoints.

  • Kidney disease studies

    Preclinical models for CKD, DKD and AKI with pharmacology, biomarkers, histology and 3D imaging.

  • Lung (IPF) studies

    Bleomycin-induced IPF mouse models with pulmonary function, histopathology and transcriptomic readouts.

  • Diabetes studies

    Preclinical diabetes assessment services using disease models and translational endpoints.

  • Women’s health studies

    Preclinical studies in POI and PCOS models to assess novel compounds.

  • Muscle (sarcopenia) studies

    Integrated muscle research platform for profiling drug candidates in sarcopenia-related work.

7 more services
  • Non-rodent studies
  • 3D imaging services
  • 2D histology
  • RNAseq services
  • Peptide drug discovery
  • Drug development
  • Venture creation and incubation

Capabilities

Assays and studies
  • Rodent models
  • Peptides
  • In vivo
  • Histopathology
  • Small molecules
  • NGS
15 more
  • In vivo pharmacology
  • Ex vivo assays
  • Drug profiling
  • 2D histology
  • 3D whole brain imaging
  • Whole organ imaging
  • Energy expenditure
  • Metabolic profiling
  • Body composition
  • Acute food intake monitoring
  • Biomarker analysis
  • Full metabolic assessment
  • Biochemical assessment
  • NAS scoring
  • Fibrosis scoring
Scale and capacity
More than 300 scientists and experts
Therapeutic areas
  • Liver (MASH)
  • Obesity
  • Kidney
  • Lung (IPF)
  • CNS
  • Diabetes
  • Women’s Health
  • Muscle (Sarcopenia)

Instruments and platforms

  • AI-based histology pipeline
  • Whole body plethysmography
  • Spirometry
  • 3D imaging technologies
  • GubraView

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Peptide
  • Viral vector
Species and models
  • Mouse
  • Rat
  • Miniature pig
  • C57BL/6J mice
  • DIO mouse
  • DIO rat
8 more
  • GAN DIO-MASH mouse
  • CDAA-HFD mouse
  • UUO mouse
  • ADI CKD mouse
  • uIRI mouse
  • 5/6 nephrectomy rat
  • ReninAAV UNx db/db mouse
  • Bleomycin-induced IPF mouse

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

Company

Type
CRDMO
Founded
2020
Team
More than 300 scientists and experts
Quality
AALAC-I accreditation (animal research program) · Quality management system (data integrity and controlled documentation)

Locations

Office
2 Stonecutter Street) or via Webcast. Presentaion (PDF) Webcast video London and online In
Sites
  • Boston, United States
  • Basel, Switzerland
Serves
Worldwide, global partners

Similar labs